Skip to main content
. 2015 Feb 9;56(2):503–509. doi: 10.3349/ymj.2015.56.2.503

Fig. 3.

Fig. 3

Patient 3 with breast cancer. Comparison of (A) contrast-enhanced T1-weighted MR image before treatment, (B) contrast-enhanced T1-weighted MR image at 90 days after treatment; note the newly-developed linear, non-perfused area (arrows) at the anterior periosteum of the femur.